Actively Recruiting
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
Led by University of Alabama at Birmingham · Updated on 2026-05-08
50
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate if office-based injection of a local anesthetic/steroid combination at the area of one superior laryngeal nerve can decrease cough frequency and alleviate symptoms of chronic cough in patients with neurogenic cough.
CONDITIONS
Official Title
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Ability to speak and understand English
- Ability to provide informed consent
- Cough lasting 8 weeks or more with suspected nerve-related cause based on history
- Persistent cough despite treatment of reflux, asthma, and allergic causes as per clinical workup
You will not qualify if you...
- Age under 18 years
- Unable or unwilling to provide informed consent
- Known cough cause other than nerve irritation (e.g., reflux, asthma, allergic rhinitis, COPD)
- Starting new neuromodulator medications at injection time
- Nissen fundoplication surgery within the last year
- Smoking within the past 5 years
- Allergy to bupivacaine or Kenalog-40
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Actively Recruiting
Research Team
B
Blake Simpson, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here